Skip to main content
Figure 1 | BMC Genomics

Figure 1

From: Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting

Figure 1

MIRU-VNTR genotypic analysis of the 56 M. tuberculosis isolates. MIRU-VNTR dendrogram of the 56 M. tuberculosis clinical isolates subjected to WGS. First-line drug susceptibility testing: I, INH; R, RIF; S, STP; E, EMB; P, PZA. Second-line drug susceptibility testing: KAN, kanamycin; AMK, amikacin; CAP, capreomycin; OFX, ofloxacin; MOX, moxifloxacin; ETH, ethionamide; PAS, para-amino salicylic acid; CS, cycloserine; na, not available, nd, not determined.

Back to article page